🧬 SinoBioData Academic Portal
Open AccessDOI: 10.12307/2026.21468Original Research

Selenium effect on human bone health and its application in bone materials

Ye Gaoqi¹,Gong Yukang¹,Chen Dejin¹,Gao WenshanĀ¹āœ‰

• Department of Orthopedics, Affiliated Hospital of Hebei University, Baoding 071000, Hebei Province, China

Read Executive PreviewQuick FAQ
Selenium effect on human bone health and its application in bone materials
Graphical Abstract / Figure
Published In
Chinese Journal of Tissue Engineering Research
Published:January 15, 2026Edition:Vol 1903, Issue 31 • pp. 100-112Citation:Ye Gaoqi et al. (2026), Chinese Journal of Tissue Engineering Research
Impact FactorPremier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of Tissue Engineering Research (中国组织巄程研究).
Sponsored Research Partner

Key Takeaways & Executive Findings

  • •• Selenium exhibits anti-inflammatory, antioxidant, and osteogenic properties, effectively improving the bone immune microenvironment. • Incorporating selenium into bone materials via mesoporous particles, nanoparticles, hydrogen bonds, or diselenide bonds reduces its toxicity and enhances bioavailability. • Selenium-modified bone materials promote bone regeneration by modulating immune responses and osteogenic gene expression, showing promise for bone defect repair. • Selenium shows therapeutic potential for Kashin-Beck disease and osteoarthritis through anti-apoptotic, antioxidant, and chondroprotective mechanisms.
Sponsored Research Highlight

Abstract

BACKGROUND: In recent years, selenium modified bone repair materials have shown great potential in the treatment of bone diseases and regenerative repair. OBJECTIVE: To summarize the construction strategies of different types of selenium modified bone repair materials, as well as the effects, mechanisms, and repair promoting effects of regulating the immune microenvironment of bone regeneration. METHODS: CNKI, WanFang, PubMed, and ScienceDirect databases were searched for literature published from database inception to 2025, using the Chinese search terms ā€œselenium, bone defect, osteoporosis, Kashin Beck disease, osteosarcomaā€ and English search terms ā€œselenium, bone defect, osteoporosis, osteoarthritis, Kashin Beck disease, osteosarcoma.ā€ By reading literature for initial screening, duplicate and irrelevant articles were excluded, and ultimately 64 articles were included for review. RESULTS AND CONCLUSION: Selenium has anti-inflammatory, antioxidant, and bone promoting properties, which can effectively improve the immune microenvironment for bone regeneration. Selenium has high toxicity, but introducing selenium into bone materials can effectively diminish the toxicity of selenium. Selenium is often incorporated into bone repair materials using methods like mesoporous particles, nanoparticles, hydrogen bonds, and covalent bonds (diselenides). In composite materials, selenium uses its antioxidant and anti-inflammatory abilities to regulate the immune microenvironment and promote osteogenic gene expression, creating an ideal microenvironment for bone defect repair and regeneration. By anti-apoptosis, promoting chondrocyte self-renewal, and regulating the cellular microenvironment, it provides a potential direction for the treatment of Kashin-Beck disease. It can improve the surrounding environment of chondrocytes through anti-apoptosis, antioxidant, anti-aging, and enhancing cartilage anabolism, offering a new perspective for the treatment of osteoarthritis. However, most current research remains at a relatively basic level, and there are still many challenges before clinical application.

1. Introduction

Bones play a vital role in the human body, supporting the body, protecting internal organs, participating in movement, storing minerals, and hematopoiesis. Selenium is a cofactor for many antioxidant enzymes, such as glutathione peroxidase, thioredoxin reductase, and superoxide dismutase, which catalyze the decomposition of lipid hydroperoxides and hydrogen peroxide in human cells under reducing conditions, thereby protecting cells and cell membranes from oxidative damage. Selenium deficiency is closely related to osteoporosis, osteoarthritis, Kashin-Beck disease, and osteosarcoma. Appropriate selenium supplementation can enhance antioxidant activity and promote osteogenesis, especially for people living in selenium-deficient areas. However, selenium is easily oxidized in air, and its oxidation products have low solubility, and some forms (e.g., inorganic selenium) are highly toxic, leading to poor bioavailability. Incorporating selenium into bone materials can improve its bioavailability, thus selenium-modified bone materials show great potential in improving the bone regeneration immune microenvironment.

Most current reviews focus on the biological properties of selenium and do not pay much attention to its application in bone disease treatment and bone repair, especially lacking systematic summaries of natural selenium types, incorporation methods, and the impact of selenium incorporation on material properties. This review summarizes the construction strategies of different types of selenium-modified bone repair materials, their effects on the immune microenvironment at bone defect sites, mechanisms of action, and mechanisms promoting bone regeneration, providing a reference for future research on selenium-modified bone repair materials.

SinoBioData Interactive Document Reader
Page 1–5 of Preview
100%
Download Full PDF

Loading authentic research manuscript (Pages 1–5)...

Sponsored Research Partner
Cite This Research Paper
Ye Gaoqi, Gong Yukang, Chen Dejin, Gao Wenshan (2026). Selenium effect on human bone health and its application in bone materials. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21468
SinoBioData Academic & Legal Disclaimer

Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.

Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.

Frequently Asked Questions

What are the key properties of selenium that benefit bone health?

Selenium has anti-inflammatory, antioxidant, and osteogenic properties, which help improve the immune microenvironment for bone regeneration and protect against oxidative damage.

How is selenium incorporated into bone repair materials to reduce toxicity?

Selenium is often incorporated into bone materials using methods such as mesoporous particles, nanoparticles, hydrogen bonds, and covalent bonds (diselenides), which effectively diminish its toxicity and improve bioavailability.

What bone diseases can selenium-modified materials potentially treat?

Selenium-modified materials show potential for treating bone defects, osteoporosis, Kashin-Beck disease, and osteoarthritis by modulating immune responses, promoting osteogenesis, and protecting chondrocytes.

What are the challenges for clinical application of selenium-modified bone materials?

Challenges include the narrow safe dose range of selenium, individual variability in selenium requirements, unclear mechanisms of selenium on bone cells, and the need for stable and safe selenium-loaded bone repair materials.

Recommended Scientific Literature & Research Partners

Related Technical Papers & Translations

Research Paper
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis

Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.

Read Abstract & PDF
Research Paper
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials

Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.

Read Abstract & PDF
Research Paper
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.

Read Abstract & PDF